The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy
Open accessAbstract
Udgivelsesdato: 2008-Jul-8
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Friis-Møller, N., Weber, R., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Mateu, S., Law, M., et al. (2003) · AIDS · doi:10.1097/00002030-200305230-00010 · Cited by 1,077
Self-citationBozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625
Impact of HIV infection and HAART on serum lipids in men
Riddler, S. A. (2003) · JAMA · doi:10.1001/jama.289.22.2978 · Cited by 624
Hsue, P. Y., Lo, J. C., Franklin, A., Bolger, A. F., Martin, J. N., Deeks, S. G., & Waters, D. D. (2004) · Circulation · doi:10.1161/01.cir.0000124480.32233.8a · Cited by 588
Mary-Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 564
Coronary Heart Disease in HIV-Infected Individuals
Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., Maa, J.-F., & Hodder, S. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308010-00012 · Cited by 537
Self-citationSevere premature coronary artery disease with protease inhibitors
Henry, K., Melroe, H., Huebsch, J., Hermundson, J., Levine, C., Swensen, L., & Daley, J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79053-x · Cited by 513
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Greenberg, A. E., & Janssen, R. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11672-2 · Cited by 488
Klein, D., Hurley, L. B., Quesenberry, C. P., & Sidney, S. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200208150-00002 · Cited by 420
Self-citationSaves, M., Chene, G., Ducimetiere, P., Leport, C., Le Moal, G., Amouyel, P., Arveiler, D., Ruidavets, J.-B., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 400
Obel, N., Thomsen, H. F., Kronborg, G., Larsen, C. S., Hildebrandt, P. R., Sorensen, H. T., & Gerstoft, J. (2007) · Clinical Infectious Diseases · doi:10.1086/518285 · Cited by 331
Law, M., Friis‐Møller, N., El‐Sadr, W., Weber, R., Reiss, P., D'Arminio Monforte, A., Thiébaut, R., Morfeldt, L., De Wit, S., Pradier, C., et al. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00362.x · Cited by 298
Self-citationPremature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy
Depairon, M., Chessex, S., Sudre, P., Rodondi, N., Doser, N., Chave, J.-P., Riesen, W., Nicod, P., Darioli, R., Telenti, A., et al. (2001) · AIDS · doi:10.1097/00002030-200102160-00005 · Cited by 273
Vascular complications associated with use of HIV protease inhibitors
Gallet, B., Pulik, M., Genet, P., Chedin, P., & Hiltgen, M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78643-8 · Cited by 253
Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults
Wu, Y., Liu, X., Li, X., Li, Y., Zhao, L., Chen, Z., Li, Y., Rao, X., Zhou, B., Detrano, R., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.607499 · Cited by 247
Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
Maggi, P., Serio, G., Epifani, G., Fiorentino, G., Saracino, A., Fico, C., Perilli, F., Lillo, A., Ferraro, S., Gargiulo, M., et al. (2000) · AIDS · doi:10.1097/00002030-200011100-00001 · Cited by 240
Phillips, A. N., Carr, A., Neuhaus, J., Visnegarwala, F., Prineas, R., Burman, W. J., Williams, I., Drummond, F., Duprez, D., Belloso, W. H., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300215 · Cited by 240
Self-citationTen-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women
Kaplan, R. C., Kingsley, L. A., Sharrett, A. R., Li, X., Lazar, J., Tien, P. C., Mack, W. J., Cohen, M. H., Jacobson, L., & Gange, S. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521935 · Cited by 220
Lorenz, M. W., Stephan, C., Harmjanz, A., Staszewski, S., Buehler, A., Bickel, M., von Kegler, S., Ruhkamp, D., Steinmetz, H., & Sitzer, M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.022 · Cited by 196
Thomsen, T. F., McGee, D., Davidsen, M., & Jørgensen, T. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.4.817 · Cited by 186
Rickerts, V., Brodt, H., Staszewski, S., & Stille, W. (2000) · PubMed · Cited by 149
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV‐infected patients
Iloeje, U., Yuan, Y., L’Italien, G. J., Mauskopf, J., Holmberg, S. D., Moorman, A. C., Wood, K., & Moore, R. D. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00265.x · Cited by 137
Seminari, E. M., Pan, A., Voltini, G., Carnevale, G., Maserati, R., Minoli, L., Meneghetti, G., Tinelli, C., & Testa, S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00736-5 · Cited by 127
Cooper, J. A., Miller, G. J., & Humphries, S. E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.026 · Cited by 123
van Wijk, J. P. H., de Koning, E. J. P., Cabezas, M. C., Joven, J., Roodt, J. O. ’., Rabelink, T. J., & Hoepelman, A. I. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.073 · Cited by 115
Vascular complications associated with use of HIV protease inhibitors
Vittecoq, D., Escaut, L., & Jj, M. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78644-x · Cited by 107
Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients*
Mercié, P., Thiébaut, R., Aurillac-Lavignolle, V., Pellegrin, J., Yvorra-Vives, M. C., Cipriano, C., Neau, D., Morlat, P., Ragnaud, J., Dupon, M., et al. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00324.x · Cited by 96
Johnsen, S., Dolan, S. E., Fitch, K. V., Kanter, J. R., Hemphill, L., Connelly, J. M., Lees, R. S., Lee, H., & Grinspoon, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1140 · Cited by 94
Subclinical Carotid Atherosclerosis in HIV-Infected Patients
Jericó, C. R., Knobel, H., Calvo, N., Sorlí, L., Guelar, A., Gimeno, J. L., Saballs, P., López-Colomés, J. L., & Pedro‐Botet, J. (2006) · Stroke · doi:10.1161/01.str.0000204037.26797.7f · Cited by 92
JOY, T. R., Keogh, H. M., Hadigan, C. M., Lee, H., Dolan, S. E., Fitch, K. V., Liebau, J., Lo, J., Johnsen, S., Hubbard, J. L., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32823644ff · Cited by 70
COPLAN, P. M., Nikas, A. A., Japour, A. J., Cormier, K., Kremers, H. M., Lewis, R., Xu, Y., & DiNubile, M. J. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203766774487 · Cited by 61
Rosengren, A., Hagman, M., Wedel, H., & Wilhelmsen, L. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015340 · Cited by 50
Neumann, T., Woiwod, T., Neumann, A., Miller, M., von Birgelen, C., Volbracht, L., Esser, S., Brockmeyer, N. H., Gerken, G., & Erbel, R. (2004) · PubMed · Cited by 41
Mensah, G. A., Dietz, W. H., Harris, V. B., Henson, R. M., Labarthe, D. R., Vinicor, F., & Wechsler, H. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.07.035 · Cited by 36
Cited by
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Carnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147
Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Duprez, D. A., Neuhaus, J., Kuller, L. H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044454 · Cited by 520
Self-citationMicrobial translocation in HIV infection: causes, consequences and treatment opportunities
Sandler, N. G., & Douek, D. C. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2848 · Cited by 472
Metadata
- Authors
- Currier, J. S., Lundgren, J. D., Carr, A., Klein, D., Sabin, C. A., Sax, P. E., Schouten, J. T., Smieja, M., & for Working Group 2
- Venue
- Circulation
- Published
- 2008-07-08
- Volume
- 118
- Issue
- 2
- Pages
- e29-35
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2133107090
- Cited by
- 368
- References
- 42
- FWCI
- 26.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.